News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.
Jul 4, 2024, 10:04

Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.

Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and President at Pager Publications, shared a post on X:

“ViPOR in LBCL NEJM by Christopher Melani et al.:

  • 20 pts Ph1b / 40 Ph2; RP2D ven 800 mg
  • ORR 54% overall: 62% (all CRs!) in non-GC, 67% (CR 53%) in DHL with BCL2
  • 2-yr DOCR 78% w/o consolidation, post-CAR 2-yr PFS 30%

Great activity in high-risk R/R subtypes!”

Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al. Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.

Read further.
Source: Ajay Major/X

Ajay Major cancer Cancer research cancer treatment chemotherapy clinical trials Healthcare Innovations immunotherapy medical oncology OncoDaily Oncology Oncology News patient care Precision Medicine
Special Coverage
Science
Feb 22, 2025, 15:33
Updated ESMO Clinical Practice Guideline on Hepatocellular Carcinoma
Science
Feb 22, 2025, 15:14
Erman Akkus: Stage specific characterization of early-onset colorectal cancer
Blog
Feb 22, 2025, 15:04
John Gordon: Successful CAR Tcell Therapy - "It's a Bug's Life"
Blog
Feb 22, 2025, 14:43
Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?
Science
Feb 22, 2025, 14:10
Yan Leyfman: Advancing CAR T-Cell Therapy - Off-the-Shelf Allogeneic Approach
Science
Feb 22, 2025, 13:28
Elvina Almuradova: Immunotherapy for HPV-Associated Cancers
Opinion
Feb 22, 2025, 13:10
Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding
Science
Feb 22, 2025, 13:10
Why immunotherapy has struggled in EGFR+ lung cancer - EGFR Positive Lung Cancer UK
Blog
Feb 22, 2025, 13:04
Debate session on the management of stage III NSCLC in the IO era - ESTRO
Celebrities
Feb 22, 2025, 11:40
Remembering Saxophonist James Casey: His Battle with Colon Cancer and Advocacy
Career
Feb 22, 2025, 11:36
Joseph H. Antin Received ASTCT Lifetime Achievement Award at 2025 Tandem Meetings
Science
Feb 22, 2025, 11:28
Myeloma Paper of the Day, February 22nd, suggested by Robert Orlowski